# Vitamin D Bone Density Meta-analysis: What the Evidence Says Canonical: https://www.migaku.app/guides/vitamin-d-bone-density-meta-analysis-evidence-review Category: evidence-review Summary: Vitamin D Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mi Last reviewed: 2026-05-26 Reviewed by: Migaku Evidence Review # Vitamin D Bone Density Meta-analysis: What the Evidence Says ## Quick Answer Vitamin D Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice. ## Key Takeaways - This page is generated only from sources stored in the Migaku evidence knowledge base. - Current evidence mix: 1 observational study, 1 research article. - Claims should be interpreted with the source type, study design, population, and publication date in mind. - This article is educational and does not replace care from a qualified clinician. ## Evidence Map | Source | Evidence type | Level | Date | Identifier | | --- | --- | ---: | --- | --- | | The Impact of Serum 25‐Hydroxyvitamin D on Bone Mineral Density at Different Skeletal Sites: A Multivariate Analysis Based on a UK Cohort Study | observational study | 3 | 2026-05-17 | 10.1002/fsn3.71894 | | Editorial: Vitamin D and aging: associations with mortality, cognition, chronic diseases, and metabolic conditions in elderly individuals | research article | 4 | 2026-04-16 | 10.3389/fendo.2026.1830429 | ## What The Sources Report - High-quality meta-analyses of randomized clinical trials (RCT) found that vitamin D supplementation would help increase the BMD in the femur neck area but not at other sites (Reid et al. ). [Zeng Hualian (2026); evidence level 3] - Furthermore, large-scale trials, such as the VITAL trial, have demonstrated that supplemental vitamin D3 (2000 IU/day) did not result in significant bone density changes compared to placebo at the spine, hip, or total body in generally healthy adults (LeBoff et al. ). [Zeng Hualian (2026); evidence level 3] - Aging amplifies the risk of vitamin D inadequacy through reduced cutaneous synthesis, impaired renal and hepatic activation, and diminished sun exposure. [Li Yupeng (2026); evidence level 4] - A recent global meta-analysis found that approximately 59.7% (95% CI 45.9-72.1) of elderly individuals are vitamin D-deficient (<20 ng/mL). [Li Yupeng (2026); evidence level 4] ## How To Read This Evidence Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade. ## Practical Interpretation For vitamin d bone density meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources. ## Limits Of This First Pass This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review. ## References - Zeng Hualian (2026). The Impact of Serum 25‐Hydroxyvitamin D on Bone Mineral Density at Different Skeletal Sites: A Multivariate Analysis Based on a UK Cohort Study. DOI: 10.1002/fsn3.71894. PMCID: PMC13180784. PMID: 42157955. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13180784/ - Li Yupeng (2026). Editorial: Vitamin D and aging: associations with mortality, cognition, chronic diseases, and metabolic conditions in elderly individuals. DOI: 10.3389/fendo.2026.1830429. PMCID: PMC13128371. PMID: 42077437. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13128371/ ## Safety Note Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.